Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Open, Multicenter Study on the Efficacy and Safety of Arbidol Hydrochloride Tablets in Treating Pneumonia in Patients Infected With Novel Coronavirus (2019-ncov).

NCT04260594 is registered in ClinicalTrials.gov with Jieming QU as lead sponsor.

NCT NCT04260594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04260594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Open, Multicenter Study on the Efficacy and Safety of Arbidol Hydrochloride Tablets in Treating Pneumonia in Patients Infected With Novel Coronavirus (2019-ncov).
Lead sponsor
Jieming QU
Phase
Phase 4
Overall status
Completed
Start date
February 8, 2020
Completion date
December 30, 2020
Enrollment
236 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

2019-ncov